Lixte Biotechnology Holdings, Inc.
LIXT
$5.16
$0.122.38%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.77M | 1.75M | 714.20K | 615.50K | 578.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.82M | 1.80M | 774.80K | 706.90K | 613.50K |
| Operating Income | -1.82M | -1.80M | -774.80K | -706.90K | -613.50K |
| Income Before Tax | -2.54M | -1.98M | -775.70K | -709.60K | -617.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.54M | -1.98M | -775.70K | -709.60K | -617.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.54M | -1.98M | -775.70K | -709.60K | -617.70K |
| EBIT | -1.82M | -1.80M | -774.80K | -706.90K | -613.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.32 | -0.33 | -0.29 | -0.29 | -0.27 |
| Normalized Basic EPS | -0.20 | -0.20 | -0.18 | -0.18 | -0.17 |
| EPS Diluted | -0.32 | -0.33 | -0.29 | -0.29 | -0.27 |
| Normalized Diluted EPS | -0.20 | -0.20 | -0.18 | -0.18 | -0.17 |
| Average Basic Shares Outstanding | 7.96M | 6.17M | 2.72M | 2.47M | 2.25M |
| Average Diluted Shares Outstanding | 7.96M | 6.17M | 2.72M | 2.47M | 2.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |